Intraoperative Parathyroid Hormone Monitoring In Normohormonal Primary Hyperparathyroidism: How Low Do You Go?
The Laryngoscope · 2024
DOI: 10.1002/lary.31076 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Richard H Law und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Henry Ford Health, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Parathyroid Hormone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
The primary goal of this study was to determine in patients with normohormonal primary hyperparathyroidism (NHHPT) what percent reduction in post‐excision intraoperative parathyroid hormone (IOPTH) from baseline would yield a rate of cure comparable to that in patients with classical primary hyperparathyroidism (PHPT).
Methods
This is a retrospective cohort study of patients who underwent parathyroidectomy between July 2013 and February 2020. Demographic data, preoperative, intraoperative, and postoperative metrics were collected. Patients with NHHPT were compared to those with classical PHPT. Subgroup analyses were performed.
Results
Of the 496 patients included in the study, 66 (13.3%) were of the normohormonal variant based on preoperative intact parathyroid hormone (PTH) levels and 28 (5.6%) based on baseline IOPTH levels. The cure rates in the two normohormonal groups were not significantly different from their classical counterparts (98.4% and 100.0% vs. 97.1%, p = 1.000). The median percent decline in post‐excision IOPTH from baseline that achieved cure in the normohormonal groups were 82.6% and 80.4% compared to their respective controls at 87.3%, p = 0.011 and p = 0.001 . Although the rate of multiglandular disease was higher in one of the normohormonal variant groups, this difference was due to a higher rate of double adenomas, not four‐gland hyperplasia.
Conclusion
Patients with NHHPT undergoing parathyroidectomy can expect cure rates similar to that in patients with classical PHPT. The results of this study indicate that achieving an 80% drop or more in IOPTH levels predicts a high likelihood of cure. This is true irrespective of whether the patient is deemed normohormonal based on preoperative or intraoperative testing. Level of Evidence 3 Laryngoscope , 134:2480–2484, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Henry Ford Health, Detroit, Michigan, USA.
- Department of Otolaryngology-Head and Neck Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
- Department of Public Health Sciences, Henry Ford Hospital, Detroit, Michigan, USA.
ORCID-Profile: Richard H Law, Katherine A Larrabee, Michael C Singer
Zitieren
APA
Law, R. H., Larrabee, K. A., Stefan, A. J., Quan, D. L., Peterson, E. L., & Singer, M. C. (2024). Intraoperative Parathyroid Hormone Monitoring In Normohormonal Primary Hyperparathyroidism: How Low Do You Go?. The Laryngoscope. https://doi.org/10.1002/lary.31076
Vancouver
Law RH, Larrabee KA, Stefan AJ, Quan DL, Peterson EL, Singer MC. Intraoperative Parathyroid Hormone Monitoring In Normohormonal Primary Hyperparathyroidism: How Low Do You Go?. The Laryngoscope. 2024. doi:10.1002/lary.31076
BibTeX
@article{Law2024,
author = {Law, Richard H and Larrabee, Katherine A and Stefan, Andrew J and Quan, Daniel L and Peterson, Edward L and Singer, Michael C},
title = {Intraoperative Parathyroid Hormone Monitoring In Normohormonal Primary Hyperparathyroidism: How Low Do You Go?},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31076}
}
EUVIMED